[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"health-study-detail:100618451":3},{"organization":4,"armGroups":7,"interventions":19,"overallOfficials":25,"centralContacts":29,"locations":25,"responsibleParty":39,"collaborators":25,"id":43,"slug":25,"hasResults":44,"nctId":45,"briefTitle":46,"officialTitle":46,"acronym":25,"eligibilityCriteria":47,"healthyVolunteers":44,"sex":48,"minAge":49,"maxAge":50,"enrollmentInfo":51,"targetDuration":25,"studyType":54,"phases":55,"briefSummary":58,"conditions":59,"keywords":25,"overallStatus":61,"whyStopped":25,"lastUpdateSubmitDate":62,"lastUpdatePostDateStruct":63,"startDateStruct":66,"completionDateStruct":68,"leadSponsor":70,"locationsCount":25},{"fullName":5,"class":6},"Combined Military Hospital Abbottabad","OTHER",[8,14],{"label":9,"type":10,"description":11,"interventionNames":12},"1% Clotrimazole","EXPERIMENTAL","topical 1 % clotrimazole twice daily for 2 weeks",[13],"Drug: Topical 1 % clotrimazole twice daily 2 weeks",{"label":15,"type":10,"description":16,"interventionNames":17},"Itraconazole","Oral itraconazole 200mg daily 5 days",[18],"Drug: Oral itraconazole 200mg daily for 5 days",[20,26],{"type":21,"name":22,"description":23,"armGroupLabels":24,"otherNames":25},"DRUG","Topical 1 % clotrimazole twice daily 2 weeks","Topical 1% clotrimazole twice daily for 2 weeks",[9],null,{"type":21,"name":27,"description":27,"armGroupLabels":28,"otherNames":25},"Oral itraconazole 200mg daily for 5 days",[15],[30,35],{"name":31,"role":32,"phone":33,"phoneExt":25,"email":34},"Zaeema Aman, MBBS","CONTACT","+923200400726","zaeema.aman@gmail.com",{"name":36,"role":32,"phone":37,"phoneExt":25,"email":38},"Ali Amar, MBBS, FCPS","+923215625426","docaliamar@gmail.com",{"type":40,"investigatorFullName":41,"investigatorTitle":42,"investigatorAffiliation":5,"oldNameTitle":25,"oldOrganization":25},"PRINCIPAL_INVESTIGATOR","Zaeema Aman","Resisent Dermatology","100618451",false,"NCT07331792","Comparative Efficacy of Topical 1% Clotrimazole vs Oral Itraconazole in the Treatment of Pityriasis Versicolor","Inclusion Criteria:\n\n* Age (15-50 years)\n* Both genders\n* Sufferers of Pityriasis versicolor ( Determined by scale , erythema and pruritus)\n\nExclusion Criteria:\n\n* Pt with history of antifungals in last one month\n* Pt on immunosuppressants or steroid therapy\n* Pregnant and lactating women\n* Pt with chronic medical conditions ( Diabetes and hypertension)","ALL","15 Years","50 Years",{"count":52,"type":53},86,"ESTIMATED","INTERVENTIONAL",[56,57],"PHASE1","PHASE2","Comparative efficacy of topical 1% clotrimazole vs oral itraconazole in the treatment of pityriasis versicolor -Randomized control trial",[60],"Pityriasis Versicolor","NOT_YET_RECRUITING","2026-01-05",{"date":64,"type":65},"2026-01-12","ACTUAL",{"date":67,"type":53},"2026-02-02",{"date":69,"type":53},"2026-05-31",{"name":5,"class":6}]